Evidence map›Paper›PMID 42468513›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Phosphorylation-Facilitated CKB Lactylation At K11 By GCN5 Enhances Creatine Kinase Activity and Mitigates Neuronal Damage After Cerebral Ischemia-Reperfusion.

Chao Duan, Ruolin Zhang, Shihui Ding, Ying Feng, Tao Shen, Ziwei Wang, Wendai Bao, Ke Shui, Jun Qin, Jun Chen and 8 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Chao DuanHubei Provincial Clinical Research Center of Central Nervous System Repair and Functional Reconstruction, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Ruolin ZhangCollege of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China.
Shihui DingCollege of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China.
Ying FengHubei Provincial Clinical Research Center of Central Nervous System Repair and Functional Reconstruction, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Tao ShenCollege of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China.
Ziwei WangCollege of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China.
Wendai BaoCollege of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China.
Ke ShuiCollege of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China.
Jun QinHubei Provincial Clinical Research Center of Central Nervous System Repair and Functional Reconstruction, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Jun ChenDepartment of Neurology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Min ZhangCollege of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, China.
Zijing RenDepartment of Neurology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei, China.
Dongmei ZhaoDepartment of Neurology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei, China.
Xingrong GuoHubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Zhibing AiDepartment of Neurology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Xin YangDepartment of Electrical and Electronic Engineering, School of Engineering, Cardiff University, Cardiff, UK.
Peiyang ZhouDepartment of Neurology, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei, China.
Zhiqiang DongHubei Provincial Clinical Research Center of Central Nervous System Repair and Functional Reconstruction, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.ORCID https://orcid.org/0000-0001-6259-915X

Funding

Fundamental Research Funds for the Central Universities 2662022JC002Key Project of Research and Development of Hubei Province 2022BCE049National Natural Science Foundation of China 32571174Youth Fund of National Natural Science Foundation of China 32400815
6 · The paper itself

Abstract

Ischemia-reperfusion (I/R) injury in stroke causes severe neuronal damage through oxidative stress and metabolic dysfunction. Beyond its metabolic role, lactate can induce lysine lactylation, but its impact on neuroprotection remains unclear. Here, we employed integrative proteomic, lactylomic, and phosphoproteomic profiling in a murine I/R model and identified creatine kinase B-type (CKB) as a dual target of K11 lactylation and S199 phosphorylation. These modifications were found to enhance CKB enzymatic activity, promote phosphocreatine metabolism, suppress reactive oxygen species, and support neuronal survival under ischemic conditions. Mechanistically, the acetyltransferase GCN5 catalyzed K11 lactylation, while Sirt5 functioned as a delactylase. Notably, S199 phosphorylation facilitated K11 lactylation by promoting GCN5 recruitment, suggesting a hierarchical interplay between the two modifications. In vivo studies confirmed that disruption of either K11 lactylation or S199 phosphorylation impaired CKB function, exacerbated neuronal injury, and delayed functional recovery after stroke. These findings reveal a coordinated post-translational modification mechanism that enhances CKB activity and confers neuroprotection in cerebral I/R injury, offering a potential therapeutic target for stroke intervention.

Indexed as

CKBischemic strokelactylationphosphorylationproteomics

Identifiers

PMID42468513
PMCPMC13379269

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.